Ian W. Ratcliffe
Direttore/Membro del Consiglio presso Ubiquigent Ltd.
Profilo
Ian W.
Ratcliffe was the founder of Asterand Biosciences, Inc. which was founded in 2006, where he held the title of Chairman, President & Chief Executive Officer in 2013.
Currently, he holds the position of Director at Agilis Biotherapeutics LLC and Ubiquigent Ltd.
respectively.
In the past, he served as Chairman at QIAGEN Beverly LLC, Director at Global Cell Solutions, Inc., Director at NanoView Biosciences, Inc., Vice President at Serologicals Corp., and President & Chief Operating Officer at Upstate Group LLC.
He was also a Non-Executive Director at BioSeek Plc from 2008 to 2010.
Mr. Ratcliffe holds an MBA degree from the University of Virginia and an undergraduate degree from the University of Surrey.
Posizioni attive di Ian W. Ratcliffe
Società | Posizione | Inizio |
---|---|---|
Ubiquigent Ltd.
Ubiquigent Ltd. Miscellaneous Commercial ServicesCommercial Services Ubiquigent Ltd. develops reagents, kits, drug discovery assay development and compound profiling services to the academic and commercial life science research community worldwide. It focus; namely the ubiquitin, ubiquitin-like and integrated signalling systems. The company has established its scientific and business credentials with both academic researchers undertaking fundamental scientific discovery as well as with pharmaceutical and biotechnology company scientists undertaking ubiquitin system-focused drug discovery. Ubiquigent was founded by Jason Brown in 2009 and is headquartered in Dundee, the United Kingdom. | Direttore/Membro del Consiglio | - |
Agilis Biotherapeutics LLC
Agilis Biotherapeutics LLC BiotechnologyHealth Technology Agilis Biotherapeutics LLC operates as a biotechnology company. It focuses on designing and engineering first-in-class DNA-based therapeutics to improve and save the lives of patients affected by life-threatening or fatal rare diseases for which there are no or limited treatment options. The company was founded in 2013 and is headquartered in Cambridge, MA. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Ian W. Ratcliffe
Società | Posizione | Fine |
---|---|---|
BIOSEEK PLC | Direttore/Membro del Consiglio | 08/06/2010 |
NanoView Biosciences, Inc.
NanoView Biosciences, Inc. Medical SpecialtiesHealth Technology NanoView Biosciences, Inc. engages in research and development of non technology. It develops ExoView platform that provides critical information that will assist in the translation of extracellular vesicle research into the clinical and therapeutic environment. The company was founded by David Freedman and George G. Daaboul and is headquartered in Boston, MA. | Direttore/Membro del Consiglio | - |
Global Cell Solutions, Inc.
Global Cell Solutions, Inc. Pharmaceuticals: OtherHealth Technology Global Cell Solutions, Inc. provides three-dimensional cell culturing tools and cell-based assays to researchers engaged in the fields of biotechnology, drug discovery, therapeutic, and pharmaceutical researches. The company was founded by Robin A. Felder and Uday Gupta in 2004 and is headquartered in North Garden, VA. | Direttore/Membro del Consiglio | - |
QIAGEN Beverly LLC
QIAGEN Beverly LLC BiotechnologyHealth Technology Qiagen Beverly, Inc. produces reagents, kits and assays enables customers worldwide to transform patient treatment and life science research. Its products include xmal, mapl, taqiT, wgs ligase, sall, xhol and bamhi. The company was founded by Christopher Benoit and Stephen Picone in 2006 and is headquartered in Beverly, M A. | Presidente | - |
Asterand Biosciences, Inc.
Asterand Biosciences, Inc. BiotechnologyHealth Technology Asterand Biosciences, Inc. provided stem cell research products. It offered proprietary reagents and tools developed by stem cell scientists. The firm's products included small molecules for pluripotency, self-renewal and differentiation, viral-delivered transcription factors, matrices, cell lines, cytokines, antibodies and transfection reagents. The company was founded by Ian W. Ratcliffe, Stephen M. Chang and Sheng Ding in 2006 and headquartered in Detroit, MI. | Amministratore Delegato | - |
Formazione di Ian W. Ratcliffe
University of Virginia | Masters Business Admin |
University of Surrey | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 9 |
---|---|
Serologicals Corp.
Serologicals Corp. Miscellaneous Commercial ServicesCommercial Services Serologicals Corp. researches, develops and markets biological products for the life sciences market. The firm focuses in areas such as are cell culture supplements, molecular reagents and diagnostic antibodies. Its applications include cardiology, hematology, infectious diseases, immunology, molecular biology and oncology. It has operations in Australia, Canada, Scotland, and United Kingdom. The company was founded in 1971 by Samuel A. Penninger and is located in Norcross, GA. | Commercial Services |
QIAGEN Beverly LLC
QIAGEN Beverly LLC BiotechnologyHealth Technology Qiagen Beverly, Inc. produces reagents, kits and assays enables customers worldwide to transform patient treatment and life science research. Its products include xmal, mapl, taqiT, wgs ligase, sall, xhol and bamhi. The company was founded by Christopher Benoit and Stephen Picone in 2006 and is headquartered in Beverly, M A. | Health Technology |
Asterand Biosciences, Inc.
Asterand Biosciences, Inc. BiotechnologyHealth Technology Asterand Biosciences, Inc. provided stem cell research products. It offered proprietary reagents and tools developed by stem cell scientists. The firm's products included small molecules for pluripotency, self-renewal and differentiation, viral-delivered transcription factors, matrices, cell lines, cytokines, antibodies and transfection reagents. The company was founded by Ian W. Ratcliffe, Stephen M. Chang and Sheng Ding in 2006 and headquartered in Detroit, MI. | Health Technology |
Global Cell Solutions, Inc.
Global Cell Solutions, Inc. Pharmaceuticals: OtherHealth Technology Global Cell Solutions, Inc. provides three-dimensional cell culturing tools and cell-based assays to researchers engaged in the fields of biotechnology, drug discovery, therapeutic, and pharmaceutical researches. The company was founded by Robin A. Felder and Uday Gupta in 2004 and is headquartered in North Garden, VA. | Health Technology |
Agilis Biotherapeutics LLC
Agilis Biotherapeutics LLC BiotechnologyHealth Technology Agilis Biotherapeutics LLC operates as a biotechnology company. It focuses on designing and engineering first-in-class DNA-based therapeutics to improve and save the lives of patients affected by life-threatening or fatal rare diseases for which there are no or limited treatment options. The company was founded in 2013 and is headquartered in Cambridge, MA. | Health Technology |
Upstate Group LLC
Upstate Group LLC Pharmaceuticals: MajorHealth Technology Upstate Group LLC develops cell signaling products, technology platforms and services. It provides researchers at pharmaceutical and biotechnology companies, universities and government agencies with advanced tools to accelerate life science research and drug discovery. Upstate Group is a subsidiary of Serologicals Corp. The company was founded in 1988 and is headquartered in Charlottesville, VA. | Health Technology |
BioSeek Plc
BioSeek Plc Miscellaneous Commercial ServicesCommercial Services BioSeek Plc provides human tissue-based research services for the pharmaceutical industry. It focuses on applying human primary cell assays and predictive disease models to the discovery and development of human therapeutics and safer chemicals. The company was founded by Eugene Butcher in March 1996 and is headquartered in London, the United Kingdom. | Commercial Services |
NanoView Biosciences, Inc.
NanoView Biosciences, Inc. Medical SpecialtiesHealth Technology NanoView Biosciences, Inc. engages in research and development of non technology. It develops ExoView platform that provides critical information that will assist in the translation of extracellular vesicle research into the clinical and therapeutic environment. The company was founded by David Freedman and George G. Daaboul and is headquartered in Boston, MA. | Health Technology |
Ubiquigent Ltd.
Ubiquigent Ltd. Miscellaneous Commercial ServicesCommercial Services Ubiquigent Ltd. develops reagents, kits, drug discovery assay development and compound profiling services to the academic and commercial life science research community worldwide. It focus; namely the ubiquitin, ubiquitin-like and integrated signalling systems. The company has established its scientific and business credentials with both academic researchers undertaking fundamental scientific discovery as well as with pharmaceutical and biotechnology company scientists undertaking ubiquitin system-focused drug discovery. Ubiquigent was founded by Jason Brown in 2009 and is headquartered in Dundee, the United Kingdom. | Commercial Services |
- Borsa valori
- Insiders
- Ian W. Ratcliffe